PATENT CLAIM ANALYSIS

Application Number: 15875695
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "131100"]

Abstract:
Methods and compositions for enhancing an immune response in a subject (e.g., an immunocompromised subject or a subject with systemic lupus erythematosus (SLE)) are described. In particular, methods of administering to the subject an effective amount of an anti-signaling lymphocytic activation molecule family member 7 (SLAMF7)-antibody or antigen binding fragment thereof are described.

Claim (Index 10):
The method of  claim 7 , wherein the route of administration of the pharmaceutical composition to the subject is selected from the group consisting of intramuscularly, subcutaneously, parenterally, orally, intranasally, intradermally, transdermally, intraperitoneally, intratracheally, topically, rectally, and pulmonarily.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.3617
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14935937', '15142538', '15661584', '10466023', '15239569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493840499173912
- 35 USC 102 Novelty (BERT): 0.52984307898948
- Combined Prediction Score: 0.7274299528246001
- Mean Citation Score: 306.377952
- Max Citation Score: 315.16696
- Similarity Product: 178.7350116037417

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test